JPRN-UMIN000005772招募中4 期
Clinical efficacy and safety of double dose (200 mg tid) CDTR-PI based on scoring system for adult acute pharyngotonsillitis - Clinical efficacy of double dose CDTR-PI for adult acute pharyngotonsillitis
research association of okayama clinican0 个研究点目标入组 100 人开始时间: 2011年7月1日最近更新:
适应症
试验速览
- 阶段
- 4 期
- 状态
- 招募中
- 发起方
- 入组人数
- 100
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
- 年龄范围
- 16years-old 至 ot applicable（—）
- 性别
- All
入选标准
- 未提供
排除标准
- •- Cases with definite improvement of symptoms or observations by previous treatment of other antibiotics within 7 days before administration. - Cases of atypical infection caused by bacteria out of indication (eg. mycoplasma, chlamydia). - Cases with serious or progressive underlying disease/complication, hard to evaluate efficacy and safety. - Cases with severe renal function disorder (Ccr < 30 mL/min and/or on hemodialysis) - Cases with a history of hypersensitivity for cephalosporins and/or penicillins - Cases with concomitant use of other antibiotics (excluding the long-term, low dose macrolides therapy) - Other cases which doctor in charge decide that the patient is not suitable for the study
研究者
相似试验
尚未招募
2 期
Study on Hepatitis B vaccine dosage on children with chronic kidney diseaseCTRI/2018/06/014435Chacha Nehru Bal Chikitsalaya
已完成
不适用
Evaluation of Two Doses of QVAR by Breath Operated and Metered Dose Inhalers in Asthmatic ChildrePER-048-05IVAX RESEARCH, INC.,
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyEUCTR2013-000473-68-DEGrünenthal GmbH699
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyModerate to severe chronic pain due to diabetic peripheral neuropathy (DPN) requiring analgesia in subjects with well-controlled and stable type 1 or type 2 diabetes mellitus.MedDRA version: 16.0Level: PTClassification code 10012680Term: Diabetic neuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000473-68-ESGrünenthal GmbH540
进行中（未招募）
不适用
Clinical trials assessing efficacy, safety and tolerability of different doses of oral cebranopadol in patients with moderate to severe chronic pain due to diabetic peripheral neuropathyModerate to severe chronic pain due to diabetic peripheral neuropathy (DPN) requiring analgesia in subjects with well-controlled and stable type 1 or type 2 diabetes mellitus.MedDRA version: 16.0Level: PTClassification code 10012680Term: Diabetic neuropathySystem Organ Class: 10029205 - Nervous system disordersEUCTR2013-000473-68-BEGrünenthal GmbH540